Annual accounts
Total Exemption Full accounts
30/09/2027Filing deadline
Made up to 31/12/2025Due 30/09/2027
- Next accounts made up to
- 31/12/2026
- Last accounts made up to
- 31/12/2025
OXFORD CANCER BIOMARKERS LIMITED
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- C/O Douglas Mcdonald Ca, 2 Octavia Buildings, Kilmacolm PA13 4AE
- Classification (SIC)
- Other human health activities (86.90 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 25/06/2026View PDF (11 pages)
Total exemption full accounts made up to 2025-12-31
- 27/01/2026View PDF (5 pages)
Confirmation statement made on 2025-12-23 with updates
- 02/01/2025View PDF (8 pages)
Confirmation statement made on 2024-12-23 with updates
- 28/06/2024View PDF (4 pages)
Statement of capital following an allotment of shares on 2024-06-03
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
06/01/2027Filing deadline
Last statement 23/12/2025Due 06/01/2027
- Next statement date
- 23/12/2026
- Last statement dated
- 23/12/2025
Financial performance
The latest figures OXFORD CANCER BIOMARKERS LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£2.25K2024
106.04%vs 20232023: £-37.25K
Total Assets
£422.56K2024
-28.68%vs 20232023: £592.51K
Cash in Bank
£30.98K2024
-77.60%vs 20232023: £138.32K
Total Liabilities
£373.58K2024
-33.30%vs 20232023: £560.09K
Employees
22024
-6vs 20232023: 8
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Total liabilities moved furthest, down 33.30% on 2023. See the full financial analysis for OXFORD CANCER BIOMARKERS LIMITED.
The full financial record
Four ways through OXFORD CANCER BIOMARKERS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · -37.5% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 2 | -6 |
| 2023 | 8 | -3 |
| 2022 | 11 | -1 |
| 2021 | 12 | – |
Reported employee count decreased from 12 in 2021 to 2 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
25Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 17/04/2024–Present | 9 | |
| Director | 02/08/2011–31/03/2023 | 9 | |
| Director | 24/05/2010–18/02/2011 | 9 | |
| Director | 27/06/2017–31/12/2017 | 0 | |
| Director | 09/10/2017–19/07/2019 | 12 | |
| Director | 20/07/2021–20/05/2022 | 4 | |
| Director | 01/07/2019–13/01/2020 | 26 | |
| Director | 24/05/2010–Present | 16 | |
| Director | 17/04/2018–30/04/2019 | 3 | |
| Director | 30/01/2012–16/12/2015 | 10 | |
| Director | 16/12/2015–07/01/2020 | 34 | |
| Director | 16/12/2015–22/11/2023 | 11 | |
| Director | 11/06/2019–16/05/2023 | 12 | |
| Director | 27/01/2015–05/05/2017 | 38 | |
| Director | 01/12/2011–30/04/2012 | 21 | |
| Director | 11/06/2019–25/01/2022 | 1 | |
| Director | 25/01/2022–31/03/2023 | 1 | |
| Director | 30/01/2012–21/01/2015 | 1 | |
| Director | 26/07/2012–01/11/2013 | 4 | |
| Director | 14/12/2021–13/09/2023 | 17 | |
| Director | 15/01/2013–08/01/2020 | 0 | |
| Director | 10/09/2019–12/05/2026 | 0 | |
| Director | 22/04/2021–23/04/2024 | 0 | |
| Director | 29/05/2019–09/03/2021 | 0 | |
| Director | 31/03/2023–Present | 100 |
Persons with significant control
1Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 25
- Since 21/11/2022
- Last 12 months
- 2
- +1 vs the year before
- Most recent filing
- 25/06/2026
- 3 months ago
What changed in the last year
- Accounts filedLatest 25/06/2026
- Confirmation statementLatest 27/01/2026
Filing timeline
- 25/06/2026View PDF (11 pages)
Total exemption full accounts made up to 2025-12-31
- 27/01/2026View PDF (5 pages)
Confirmation statement made on 2025-12-23 with updates
- 02/01/2025View PDF (8 pages)
Confirmation statement made on 2024-12-23 with updates
- 28/06/2024View PDF (4 pages)
Statement of capital following an allotment of shares on 2024-06-03
- 27/06/2024View PDF (4 pages)
Statement of capital following an allotment of shares on 2024-06-03
- 26/06/2024View PDF (12 pages)
Total exemption full accounts made up to 2023-12-31
- 23/04/2024View PDF (1 pages)
Termination of appointment of Kyoung Mee Lee as a director on 2024-04-23
- 18/04/2024View PDF (2 pages)
Appointment of Professor David James Kerr as a director on 2024-04-17
- 26/03/2024View PDF (1 pages)
Resolutions
- 06/02/2024View PDF (12 pages)
Total exemption full accounts made up to 2022-12-31
- 02/01/2024View PDF (8 pages)
Confirmation statement made on 2023-12-23 with updates
- 22/11/2023View PDF (1 pages)
Termination of appointment of Dean Marc Slagel as a director on 2023-11-22
Showing 12 of 25 filings
See when the next accounts and confirmation statement are due
Similar companies
214 UK companies are similar to OXFORD CANCER BIOMARKERS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other human health activities) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
CLICK SYMPTOMS LIMITED
Active70-72 Kirkgate, Silsden, Keighley, West Yorkshire BD20 0PA
- Activity
- Other human health activities
- Company no.
- 07978513
- Incorporated
- 06/03/2012
- Employees
- 2
PHOENIX SURGERY LTD
Active17 D-F Telford Court, Chestergates Business Park, Chester CH1 6LT
- Activity
- Specialists medical practice activities
- Company no.
- 08233675
- Incorporated
- 28/09/2012
- Employees
- 2
TRUST PRIMARY CARE LTD
ActiveThe Ridge, Cousen Road, Bradford BD7 3JX
- Activity
- General medical practice activities
- Company no.
- 09147175
- Incorporated
- 25/07/2014
- Employees
- 1
FIRST BLUE HEALTHCARE LIMITED
ActiveSeighford Hall, Clanford Road, Seighford ST18 9NL
- Activity
- Medical nursing home activities
- Company no.
- 11013190
- Incorporated
- 13/10/2017
- Employees
- 1
YPS PSYCHOLOGY LTD
Active98 Middlewich Road, Northwich, Cheshire CW9 7DA
- Activity
- Other human health activities
- Company no.
- 07707080
- Incorporated
- 15/07/2011
- Employees
- 2
About OXFORD CANCER BIOMARKERS LIMITED
A short description of the company, written from its Companies House record.
OXFORD CANCER BIOMARKERS LIMITED is a private limited company registered in the United Kingdom, based in C/O Douglas Mcdonald Ca, 2 Octavia Buildings, Kilmacolm PA13 4AE. Companies House classifies its business as Other human health activities. It has been on the register for 16 years 4 months.
The register currently records it as active. Its 2024 accounts report net assets of £2.25K and 2 employees.
OXFORD CANCER BIOMARKERS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records OXFORD CANCER BIOMARKERS LIMITED under one registered business activity: Other human health activities (86.90 - SIC 2007).
OXFORD CANCER BIOMARKERS LIMITED is recorded as active on the Companies House register, and has been on it since 24/05/2010.
The most recent accounts Okredo holds cover 2024 and report net assets of £2.25K, total assets of £422.56K, cash in bank of £30.98K and total liabilities of £373.58K.
The most recent document on the record is dated 25/06/2026: Total exemption full accounts made up to 2025-12-31, 3 months ago.
On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 06/01/2027.
Companies House lists 25 officers (3 currently in post) and 1 person with significant control.